Colgate-Palmolive (NYSE:CL) COO Justin Skala sold 4,161 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $70.18, for a total transaction of $292,018.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of Colgate-Palmolive (NYSE:CL) traded up $0.91 during midday trading on Friday, hitting $70.30. The company had a trading volume of 2,325,207 shares, compared to its average volume of 4,217,950. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02. Colgate-Palmolive has a 52-week low of $68.19 and a 52-week high of $77.91. The firm has a market capitalization of $61,050.00, a P/E ratio of 26.98, a PEG ratio of 2.56 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same period last year, the company earned $0.75 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. research analysts expect that Colgate-Palmolive will post 3.18 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date was Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 61.78%.
Institutional investors have recently added to or reduced their stakes in the business. Jacobi Capital Management LLC increased its position in shares of Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after buying an additional 803 shares in the last quarter. Virtue Capital Management LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at $104,000. Krilogy Financial LLC increased its position in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new position in shares of Colgate-Palmolive in the second quarter valued at $122,000. Finally, AlphaMark Advisors LLC increased its position in shares of Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares in the last quarter. 71.52% of the stock is owned by institutional investors.
Several brokerages have commented on CL. Jefferies Group reiterated a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 26th. Societe Generale lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target on the stock. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Citigroup dropped their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research note on Thursday, November 2nd. Finally, Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and five have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $77.91.
TRADEMARK VIOLATION WARNING: This piece was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/23/colgate-palmolive-cl-coo-sells-292018-98-in-stock.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.